• Daiichi Sankyo sells Its Nihonbashi building in Japan biospectrumasia
    April 28, 2019
    As part of Daiichi Sankyo’s efforts toward the realization of its Vision for 2025 of being a “Global Pharma Innovator with competitive advantage in oncology”, the company is prioritizing resource allocation to the oncology therapeutic area
PharmaSources Customer Service